Equitable Licensing and Publicly Funded Research: A Working Model for India?

more+
less-

The patent law and access to essential medicine debate has come

a long way since the adoption of the TRIPS Agreement of 1994, and

the focus is now on new and alternative models of pharmaceutical

innovation, which can adequately meet the policy objectives of encouraging research & development (R&D) and equitable access. Indian generic medicines play a critical role in various treatment and access to medicines programs and the existing scenario in the Indian pharmaceutical market is bound to change after the implementation of new patent law. Indian government is also considering the introduction of new law that will encourage patents on publicly funded R&D. This article explores the existing models of licensing publicly funded R&D and argues that Indian government should adopt a cautious approach while introducing the new law. The article further argues that alternative incentives and R&D models such as open source and patent pools should be further explored in the Indian context.

LOADING PDF: If there are any problems, click here to download the file.


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Aziz ur Rehman, Hafiz | Attorney Advertising

Written by:

more+
less-

Aziz ur Rehman, Hafiz on:

JD Supra Readers' Choice 2016 Awards
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×
Loading...
×
×